Back

An increase in serum creatinine during intensive blood pressure therapy is not associated with adverse cardiorenal outcomes in patients with type 2 diabetes

25 August 2018 (14:00 - 14:15)
Organised by:
Congress Presentation Part of: Refining risk assessment in hypertension Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mr Didier Collard

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Pulse pressure and cardiovascular outcomes in high-risk individuals enrolled in the Systolic Blood Pressure Intervention Trial (SPRINT)
Doctor C. Byrne (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Body mass index and intensive blood pressure management in high-risk adults: insights from the systolic blood pressure intervention trial SPRINT)
Doctor M. Pareek (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Effect of wave reflection and arterial stiffness on the risk of development of hypertension in Japanese men
Doctor T. Ochiai (Ibaraki, JP)
Abstract Slides Video
Presentation thumbnail
Comparison of the prognostic significance of blood pressure measurement by unattended automatic office blood pressure and ambulatory blood pressure in subjects with chronic kidney disease
Doctor J. Seo (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Panel discussion .
Video

Access the full session

Session thumbnail
Refining risk assessment in hypertension

The Event

Event poster

ESC Congress 2018

25 August 2018 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources